116 related articles for article (PubMed ID: 12093600)
1. Smoking modulates neuroendocrine responses to ipsapirone in patients with panic disorder.
Broocks A; Bandelow B; Koch K; Bartmann U; Kinkelbur J; Schweiger U; Hohagen F; Hajak G
Neuropsychopharmacology; 2002 Aug; 27(2):270-8. PubMed ID: 12093600
[TBL] [Abstract][Full Text] [Related]
2. 5-HT1A responsivity in patients with panic disorder before and after treatment with aerobic exercise, clomipramine or placebo.
Broocks A; Meyer T; Opitz M; Bartmann U; Hillmer-Vogel U; George A; Pekrun G; Wedekind D; Rüther E; Bandelow B
Eur Neuropsychopharmacol; 2003 May; 13(3):153-64. PubMed ID: 12729940
[TBL] [Abstract][Full Text] [Related]
3. Effect of aerobic exercise on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine and to ipsapirone in untrained healthy subjects.
Broocks A; Meyer T; Gleiter CH; Hillmer-Vogel U; George A; Bartmann U; Bandelow B
Psychopharmacology (Berl); 2001 May; 155(3):234-41. PubMed ID: 11432685
[TBL] [Abstract][Full Text] [Related]
4. Increased psychological responses and divergent neuroendocrine responses to m-CPP and ipsapirone in patients with panic disorder.
Broocks A; Bandelow B; George A; Jestrabeck C; Opitz M; Bartmann U; Gleiter CH; Meineke I; Roed IS; Rüther E; Hajak G
Int Clin Psychopharmacol; 2000 May; 15(3):153-61. PubMed ID: 10870873
[TBL] [Abstract][Full Text] [Related]
5. Effects of divalproex sodium on 5-HT1A receptor function in healthy human males: hypothermic, hormonal, and behavioral responses to ipsapirone.
Shiah IS; Yatham LN; Lam RW; Zis AP
Neuropsychopharmacology; 1997 Dec; 17(6):382-90. PubMed ID: 9397426
[TBL] [Abstract][Full Text] [Related]
6. Decreased neuroendocrine responses to meta-chlorophenylpiperazine (m-CPP) but normal responses to ipsapirone in marathon runners.
Broocks A; Meyer T; George A; Hillmer-Vogel U; Meyer D; Bandelow B; Hajak G; Bartmann U; Gleiter CH; Rüther E
Neuropsychopharmacology; 1999 Feb; 20(2):150-61. PubMed ID: 9885795
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine and hypothermic effects of 5-HT1A receptor stimulation with ipsapirone in healthy men: a placebo-controlled study.
Cleare AJ; Forsling M; Bond AJ
Int Clin Psychopharmacol; 1998 Jan; 13(1):23-32. PubMed ID: 9988364
[TBL] [Abstract][Full Text] [Related]
8. Effects of short-term administration of valproate on serotonin-1A and dopamine receptor function in healthy human subjects.
Delva NJ; Brooks DL; Franklin M; al-Said K; Hawken ER; Merali Z; Lawson JS; Ravindran AV
J Psychiatry Neurosci; 2002 Nov; 27(6):429-37. PubMed ID: 12491576
[TBL] [Abstract][Full Text] [Related]
9. Ipsapirone challenge in aggressive men shows an inverse correlation between 5-HT1A receptor function and aggression.
Cleare AJ; Bond AJ
Psychopharmacology (Berl); 2000 Mar; 148(4):344-9. PubMed ID: 10928305
[TBL] [Abstract][Full Text] [Related]
10. Blunted 5-HT1A-receptor agonist-induced corticotropin and cortisol responses after long-term ipsapirone and fluoxetine administration to healthy subjects.
Berlin I; Warot D; Legout V; Guillemant S; Schöllnhammer G; Puech AJ
Clin Pharmacol Ther; 1998 Apr; 63(4):428-36. PubMed ID: 9585797
[TBL] [Abstract][Full Text] [Related]
11. In vivo drug action of tandospirone at 5-HT1A receptor examined using positron emission tomography and neuroendocrine response.
Nakayama T; Suhara T; Okubo Y; Ichimiya T; Yasuno F; Maeda J; Takano A; Saijo T; Suzuki K
Psychopharmacology (Berl); 2002 Dec; 165(1):37-42. PubMed ID: 12474116
[TBL] [Abstract][Full Text] [Related]
12. Serotonin hypothesis of winter depression: behavioral and neuroendocrine effects of the 5-HT(1A) receptor partial agonist ipsapirone in patients with seasonal affective disorder and healthy control subjects.
Schwartz PJ; Turner EH; Garcia-Borreguero D; Sedway J; Vetticad RG; Wehr TA; Murphy DL; Rosenthal NE
Psychiatry Res; 1999 Apr; 86(1):9-28. PubMed ID: 10359479
[TBL] [Abstract][Full Text] [Related]
13. Dissociable hormonal, cognitive and mood responses to neuroendocrine challenge: evidence for receptor-specific serotonergic dysregulation in depressed mood.
Riedel WJ; Klaassen T; Griez E; Honig A; Menheere PP; van Praag HM
Neuropsychopharmacology; 2002 Mar; 26(3):358-67. PubMed ID: 11850150
[TBL] [Abstract][Full Text] [Related]
14. 5-HT1A receptor-effector system responsivity in panic disorder.
Lesch KP; Wiesmann M; Hoh A; Müller T; Disselkamp-Tietze J; Osterheider M; Schulte HM
Psychopharmacology (Berl); 1992; 106(1):111-7. PubMed ID: 1346719
[TBL] [Abstract][Full Text] [Related]
15. 5-HT1A receptor function in normal subjects on clinical doses of fluoxetine: blunted temperature and hormone responses to ipsapirone challenge.
Lerer B; Gelfin Y; Gorfine M; Allolio B; Lesch KP; Newman ME
Neuropsychopharmacology; 1999 Jun; 20(6):628-39. PubMed ID: 10327431
[TBL] [Abstract][Full Text] [Related]
16. Cortisol, hypothermic, and behavioral responses to ipsapirone in patients with bipolar depression and normal controls.
Shiah IS; Yatham LN; Lam RW; Tam EM; Zis AP
Neuropsychobiology; 1998; 38(1):6-12. PubMed ID: 9701716
[TBL] [Abstract][Full Text] [Related]
17. Hypothermic, ACTH, and cortisol responses to ipsapirone in patients with mania and healthy controls.
Yatham LN; Shiah IS; Lam RW; Tam EM; Zis AP
J Affect Disord; 1999 Aug; 54(3):295-301. PubMed ID: 10467974
[TBL] [Abstract][Full Text] [Related]
18. Complex effects of age and gender on hypothermic, adrenocorticotrophic hormone and cortisol responses to ipsapirone challenge in normal subjects.
Gelfin Y; Lerer B; Lesch KP; Gorfine M; Allolio B
Psychopharmacology (Berl); 1995 Aug; 120(3):356-64. PubMed ID: 8524984
[TBL] [Abstract][Full Text] [Related]
19. Lowering of body core temperature by exposure to a cold environment and by a 5-HT1A agonist: effects on physiological and psychological variables and blood serotonin levels.
Rammsayer T; Hennig J; Bahner E; von Georgi R; Opper C; Fett C; Wesemann W; Netter P
Neuropsychobiology; 1993; 28(1-2):37-42. PubMed ID: 8255408
[TBL] [Abstract][Full Text] [Related]
20. Effects of antiglucocorticoid treatment on 5-HT1A function in depressed patients and healthy subjects.
Price LH; Cappiello A; Malison RT; McDougle CJ; Pelton GH; Schöllnhammer G; Heninger GR
Neuropsychopharmacology; 1997 Oct; 17(4):246-57. PubMed ID: 9326749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
